211 related articles for article (PubMed ID: 32268901)
1. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age.
Augusto O; Stergachis A; Dellicour S; Tinto H; Valá A; Ruperez M; Macete E; Nakanabo-Diallo S; Kazienga A; Valéa I; d'Alessandro U; Ter Kuile FO; Calip GS; Ouma P; Desai M; Sevene E
Malar J; 2020 Apr; 19(1):144. PubMed ID: 32268901
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
Saito M; McGready R; Tinto H; Rouamba T; Mosha D; Rulisa S; Kariuki S; Desai M; Manyando C; Njunju EM; Sevene E; Vala A; Augusto O; Clerk C; Were E; Mrema S; Kisinza W; Byamugisha J; Kagawa M; Singlovic J; Yore M; van Eijk AM; Mehta U; Stergachis A; Hill J; Stepniewska K; Gomes M; Guérin PJ; Nosten F; Ter Kuile FO; Dellicour S
Lancet; 2023 Jan; 401(10371):118-130. PubMed ID: 36442488
[TBL] [Abstract][Full Text] [Related]
3. Exposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in Zambia.
Manyando C; Njunju EM; Virtanen M; Hamed K; Gomes M; Van Geertruyden JP
Malar J; 2015 Feb; 14():77. PubMed ID: 25877884
[TBL] [Abstract][Full Text] [Related]
4. Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort.
Mosha D; Mazuguni F; Mrema S; Sevene E; Abdulla S; Genton B
Malar J; 2014 May; 13():197. PubMed ID: 24884890
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Saito M; Mansoor R; Kennon K; Anvikar AR; Ashley EA; Chandramohan D; Cohee LM; D'Alessandro U; Genton B; Gilder ME; Juma E; Kalilani-Phiri L; Kuepfer I; Laufer MK; Lwin KM; Meshnick SR; Mosha D; Muehlenbachs A; Mwapasa V; Mwebaza N; Nambozi M; Ndiaye JA; Nosten F; Nyunt M; Ogutu B; Parikh S; Paw MK; Phyo AP; Pimanpanarak M; Piola P; Rijken MJ; Sriprawat K; Tagbor HK; Tarning J; Tinto H; Valéa I; Valecha N; White NJ; Wiladphaingern J; Stepniewska K; McGready R; Guérin PJ
BMC Med; 2020 Jun; 18(1):138. PubMed ID: 32482173
[TBL] [Abstract][Full Text] [Related]
6. Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.
Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile F; Gutman JR; Hill J
Malar J; 2023 Sep; 22(1):262. PubMed ID: 37679753
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.
Tinto H; Sevene E; Dellicour S; Calip GS; d'Alessandro U; Macete E; Nakanabo-Diallo S; Kazienga A; Valea I; Sorgho H; Valá A; Augusto O; Ruperez M; Menendez C; Ouma P; Desai M; Ter Kuile F; Stergachis A
Reprod Health; 2015 Dec; 12():112. PubMed ID: 26637464
[TBL] [Abstract][Full Text] [Related]
8. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
9. Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso.
Rouamba T; Sondo P; Derra K; Nakanabo-Diallo S; Bihoun B; Rouamba E; Tarnagda Z; Kazienga A; Valea I; Sorgho H; Pagnoni F; Samadoulougou-Kirakoya F; Tinto H
Drug Des Devel Ther; 2020; 14():1507-1521. PubMed ID: 32368010
[TBL] [Abstract][Full Text] [Related]
10. Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.
Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile FO; Gutman JR; Hill J
Malar J; 2023 Sep; 22(1):274. PubMed ID: 37710229
[TBL] [Abstract][Full Text] [Related]
11. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.
Dellicour S; Sevene E; McGready R; Tinto H; Mosha D; Manyando C; Rulisa S; Desai M; Ouma P; Oneko M; Vala A; Rupérez M; Macete E; Menéndez C; Nakanabo-Diallo S; Kazienga A; Valéa I; Calip G; Augusto O; Genton B; Njunju EM; Moore KA; d'Alessandro U; Nosten F; Ter Kuile F; Stergachis A
PLoS Med; 2017 May; 14(5):e1002290. PubMed ID: 28463996
[TBL] [Abstract][Full Text] [Related]
12. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
Watsierah CA; Ouma C
Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
[TBL] [Abstract][Full Text] [Related]
13. Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya.
Dellicour S; Desai M; Aol G; Oneko M; Ouma P; Bigogo G; Burton DC; Breiman RF; Hamel MJ; Slutsker L; Feikin D; Kariuki S; Odhiambo F; Pandit J; Laserson KF; Calip G; Stergachis A; ter Kuile FO
Malar J; 2015 Nov; 14():461. PubMed ID: 26581434
[TBL] [Abstract][Full Text] [Related]
14. Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.
Moore KA; Simpson JA; Paw MK; Pimanpanarak M; Wiladphaingern J; Rijken MJ; Jittamala P; White NJ; Fowkes FJI; Nosten F; McGready R
Lancet Infect Dis; 2016 May; 16(5):576-583. PubMed ID: 26869377
[TBL] [Abstract][Full Text] [Related]
15. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and associated risk factors on preterm birth, low birth weight, and small for gestational age among HIV-infected pregnant women in Hunan province, 2011-2017].
Li HX; Zheng JF; Huang GW; Xiao J; Wang H; Yang M; Feng N
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1368-1374. PubMed ID: 30453439
[No Abstract] [Full Text] [Related]
17. Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester.
Clark RL
Birth Defects Res; 2020 Nov; 112(18):1403-1449. PubMed ID: 33079495
[TBL] [Abstract][Full Text] [Related]
18. Quantifying low birth weight, preterm birth and small-for-gestational-age effects of malaria in pregnancy: a population cohort study.
Rijken MJ; De Livera AM; Lee SJ; Boel ME; Rungwilailaekhiri S; Wiladphaingern J; Paw MK; Pimanpanarak M; Pukrittayakamee S; Simpson JA; Nosten F; McGready R
PLoS One; 2014; 9(7):e100247. PubMed ID: 24983755
[TBL] [Abstract][Full Text] [Related]
19. Nausea, vomiting and poor appetite during pregnancy and adverse birth outcomes in rural Nepal: an observational cohort study.
Regodón Wallin A; Tielsch JM; Khatry SK; Mullany LC; Englund JA; Chu H; LeClerq SC; Katz J
BMC Pregnancy Childbirth; 2020 Sep; 20(1):545. PubMed ID: 32943001
[TBL] [Abstract][Full Text] [Related]
20. Association of maternal serum uric acid levels with LBW/SGA: a large retrospective cohort study.
Xiong Y; Zheng P; Chen C; He C; Yang X; Cheng W
BMC Pregnancy Childbirth; 2024 Feb; 24(1):160. PubMed ID: 38395789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
